AI Assistant
Blog
Pricing
Log In
Sign Up
Idarucizumab given the nod as the first specific antidote for an oral anticoagulant
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
